Gottlieb, Alice B. http://orcid.org/0000-0002-2927-8618
Wells, Alvin F. http://orcid.org/0000-0001-7311-7689
Merola, Joseph F. http://orcid.org/0000-0001-6514-4353
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 18 October 2021
Revised: 6 January 2022
Accepted: 19 January 2022
First Online: 26 January 2022
Declarations
:
: The manuscript does not contain clinical studies or patient data.
: This manuscript did not include participants.
: This manuscript did not include participants.
: A. B. Gottlieb has received honoraria as an advisory board member and consultant for Anaptyps Bio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Incyte, GlaxoSmithKline, Janssen, LEO Pharma, Eli Lilly, Novartis, Pfizer, Sun Pharmaceutical, UCB, and XBiotech and has received research/educational grants from Boehringer Ingelheim, Incyte, Janssen, Novartis, Sun Pharmaceutical, UCB, and XBiotech. A. F. Wells has received honoraria as an advisory board member and consultant for AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis, Pfizer, and Sanofi. J. F. Merola is a consultant and/or investigator for Merck, Bristol Myers Squibb, AbbVie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sanofi, Regeneron, Arena, Sun Pharma, Biogen, Pfizer, EMD Sorono, Avotres, and LEO Pharma.